Laboratory testing may be directed toward identifying blood dyscrasias, clotting disorders and other hematological abnormalities. Suggested testing may include (but is not limited to) the following: Complete blood count with platelets (CBC with differential and platelets) CMB - comprehensive metabolic panel Prothrombin time (PT) Activated partial thromboplastin time (PTT) Activated partial thromboplastin time (APTT) An international ratio (INR) to rule out over-anticoagulation in patients taking blood thinners Antiphospholipid antibodies Homocysteine level, particularly in young men Assay for natural anticoagulants such as protein S and protein C, antithrombin III, factor V Leiden Beta-glycoprotein HIV Virus titers Anticoagulation panel for lupus if suspected autoimmune condition Sjogren’s testing panel If African American, sickle cell panel Patients taking warfarin (Coumadin, Bristol-Myers Squibb) or dabigatran (Pradaxa, Boehringer Ingelheim Pharmaceuticals) or aspir...
Link to this information/article: https://www.optometrystudents.com/clinical-guide-to-degenerative-myopia/ OTHER LINK: https://www.reviewofophthalmology.com/article/how-to-manage-pathologic-myopia --------------------------------------------------------------------------------------------------------------------------- Usually >6 D is what qualifies as degenerative myopia Several studies were conducted, and it appears that a majority of high myopes possess diffuse atrophy and fuchs spots. FUNDUS SIGNS It is important as primary eye care providers to be cognizant of the signs of degenerative myopia which commonly include: Tilting of the optic disc Peripapillary chorioretinal atrophy Vascular straightening Lacquer cracks Round, subretinal hemorrhages that clear spontaneously Fuchs spots + CNV Posterior staphyloma WSP Paving-stone degeneration and lattice degeneration Hole formation in the peripheral retina Elongation and atrophy of the cilliary body POAG Other signs: Tigroi...